Oxford Finance Provides $30MM Credit Facility to 4D pharma
4D pharma, a pharmaceutical company developing live biotherapeutic products (LBPs), a novel class of drug derived from the microbiome, closed a senior secured credit facility for up to $30 million with Oxford Finance.
August 2, 2021
4D pharma | Christopher A. Herr | Duncan Peyton | Oxford Finance
Ian Koplin